Ashwani Kumar Dhingra

Ashwani Kumar Dhingra is presently working as Professor (Pharmaceutical Chemistry) at Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India. He is having a total experience of 15+ years in academics and research. He has obtained PhD from I.K. Gujral Punjab Technical University, Jalandhar (India) in pharmaceutical sciences. He is proficient in technical writing skills as well as analysis and interpretation of data. He is having extensive knowledge of functions related to pharma R&D, product development, laboratory operations and documentation. His present areas of interest include the design and development of synthetic methodologies dealing with various organic transformations, multistep synthesis of medicinally active N-heterocyclic derivatives, and isolation & structural modification of bioactive natural compounds. He owns to his credit a total of 60 publications in national and international journals of repute, 5 book chapters, and 4 books (1 edited and 3 authored). He has published 6 design patents. He is currently editing 2 books with Nova Science, Inc. He has been awarded as Bentham Science Ambassador by Bentham Science Publishers; Highly Cited Researcher from Elsevier and Innovational Ambassador by MHRD Innovational Cell, AICTE, New Delhi. He had been on the panel of reviewers for various prestigious journals (Elsevier, Springer, Bentham Science, Frontiers, Frontiers, Taylor & Francis, etc.).

Publications

Contemporary Approaches to Mitigating Antibacterial Drug Resistance
Ajmer Singh Grewal, Ashwani Kumar Dhingra, Kunal Nepali, Geeta Deswal, Arun Lal Srivastav. © 2024. 363 pages.
In infectious disease management, antibacterial agents have long been viewed as pivotal tools in the relentless battle against microorganisms. However, the escalating threat of...
Frontiers in Combating Antibacterial Resistance: Current Perspectives and Future Horizons
Ajmer Singh Grewal, Ashwani Kumar Dhingra, Kunal Nepali, Geeta Deswal, Arun Lal Srivastav. © 2024. 422 pages.
The rise of modern antimicrobial drug resistance has evolved into a pressing global health crisis, challenging the very foundation of our ability to combat infectious diseases....